Please login to the form below
clinical trials
This page shows the latest clinical trials news and features for those working in and with pharma, biotech and healthcare.
FDA expecting boom in cell and gene therapies
Pledges clampdown on developers working outside regulations. A massive upsurge in the development of cell and gene therapies means the FDA expects to receive up to 200 applications to start trials ... The nature of gene therapy means that questions about
Latest news
-
Chinese biotechs aim PD-L1 antibody at hepatitis B
Suzhou Alphamab is already testing its PD-L1 inhibitor antibody KN035 in a number of clinical trials across tumour types in the US, China and Japan, but has licensed rights for ... Blocking the PD-1/PD-L1 pathway could be an effective immunotherapy
-
Time running out for ‘no-deal’ Brexit medicines laws
for medicines, clinical trials and medical devices are fit for purpose on exit day”. ... period. For clinical trials, the UK’s clinical trial regulatory framework will remain in place but will be subjected to slight amendments.
-
Nektar confirms BMS deal for NKTR-214 is on track
Combination trials in head and neck cancer and castration-resistant prostate cancer will start later this year. ... Almost forgotten among the interest in Nektar’s immuno-oncology pipeline – which also includes three other candidates in clinical
-
Novartis gets breakthrough tag from FDA for sickle cell drug
of these candidates are also making their way through clinical trials.
-
Pharma’s confidence in Brexit deal falls as vote looms
The latest guidance represents a ‘ramping up’ of no deal plans in seven key areas, namely: the supply of medicines and vaccines; the supply of medical devices and clinical consumables; the ... supply of non-clinical consumables, goods and services;
More from news
Approximately 157 fully matching, plus 1,545 partially matching documents found.
Latest Intelligence
-
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Recent clinical trials have offered hope that a disease-modifying therapy for Alzheimer’s disease could become available soon.Such a therapy would treat the disease at an early stage to ... Based on results from early-stage clinical trials, therapeutic
-
Is China ready for a pharmaceutical gold rush?
What’s more, requirements to carry out local clinical trials before being granted access to the Chinese market have relaxed. ... In light of recent clinical data, Keytruda is widely regarded as the better of the two checkpoint inhibitors in lung cancer.
-
AstraZeneca’s oncology renaissance
The clinical and commercial success of these three cancer therapies has helped restore self-belief among AstraZeneca employees, and will help make 2019 the year the company returns to top-line ... from clinical trials to FDA approval in just over two
-
Combined immunotherapies – potential and pitfalls
Clinical challenges All clinical trials are complex irrespective of the type of drug being tested. ... may guide the more rational design of clinical trials to improve immune surveillance and tumour control.”.
-
Leicester NHS Trust’s staff intranet is integral to HCPs’ working day
The guidelines area is particularly popular since it contains authorised and updated versions of clinical guidelines. ... How can pharma use NHS staff intranets? Pharma can post a range of content on NHS staff intranets, including clinical evidence papers
More from intelligence
Approximately 9 fully matching, plus 143 partially matching documents found.
Latest appointments
-
New hires at Nanoform, Leo Pharma and Calliditas
and bringing products to market will play a key role as we progress development of Nefecon through phase 3 clinical trials”, said Renée Aguiar-Lucander, CEO of Calliditas Therapeutics.
-
Zelluna Immunotherapy appoints chief technology officer
His experience, acquired on both side’s of the Atlantic will provide invaluable for Zelluna in its immediate focus of delivering clinical proof of concept of its TCRs in adoptive cell ... He will play a big part in the execution of Zelluna’s
-
Neurocentrx appoints two members to the board
Brooksby said: “My focus is to accelerate the business model and drive commercial clinical trials to raise international awareness of what we are offering, and enter the global market.
-
Life Healthcare appoints two new starters
Joining Alisha is Caitlin McMaster (pictured right), who takes up an account executive role at Life Healthcare, working alongside the clinical trials team.
-
Topas Therapeutics appoints chief development officer and chief medical officer
Timm Jessen, chief executive officer, Topas, said: “Rupert has a long and successful track record of bringing drugs and biologics through clinical development and regulatory approval. ... At Topas, Dr. Sandbrink will guide projects into the clinic,
More from appointments
Approximately 0 fully matching, plus 61 partially matching documents found.
Latest from PMHub
-
Digital Mobile X-Ray Devices Market Analysis, Trends, Forecast, 2016-2026
Stringent regulations, costly clinical trials and inadequate imaging infrastructure in developing economies likely to hinder the growth of the Mobile X-Ray segment. ... Increase in the number of free standing imaging centers. Request to View Sample of
-
Artificial Intelligence in Healthcare
Presently, the looming Brexit saga is casting shadows over the UK’s ability to play host to clinical trials at the frontiers of medical innovation. ... But, with a joined-up digital healthcare system, robust clinical data sets, and the help of AI, why
-
Practical Patient Centricity
Most patients just want to be better – mode of action, robust clinical trials and health economic models are not relevant to them (but are to payers and HCPs). ... Cost effective wearable technology can gather this data, enabling the ‘silent patient
-
Insights from the charity sector – from patient engagement to people-driven design
But if engagement is merely a matter of involving them in clinical trials, advisory boards, focus groups or online forums, then we are missing out on great potential for even better
-
Genetic counsellors: the new healthcare influencers?
This pioneering policy will help match patients with existing therapies or clinical trials, which are likely to improve their cancer treatment. ... Patients have no idea what they are ordering and no idea how to incorporate that into clinical
More from PMHub
Approximately 15 fully matching, plus 76 partially matching documents found.
Featured jobs
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Global Business Development Director – Health Education
-
excellent commission
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Business Director
-
Competitive Salary Offered
-
Medical Writer
-
Salary TBC
-
Associate Director
-
£75, 000-90, 000
-
Account Director
-
Competitive Salary Offered
-
Senior Medical Writer
-
Salary TBC
-
Senior Account Manager
-
Competitive Salary Offered
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Account Director, Medical Education
-
Salary TBC
-
Account Manager / Account Director
-
Competative
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- Novartis forges AI alliance with Oxford University
- FDA adcomm split on Sanofi’s type 1 diabetes drug
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
PMHub
Research Partnership
We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
